Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy

Stopped early · Phase 2

Conditions studied: BK Polyomavirus, Kidney Diseases

In brief

The purpose of this study is to assess the safety and effectiveness of a new oral immunosuppressant agent compared to standard care in renal transplant patients diagnosed with BK nephropathy.

Key facts

Study ID
NCT00104338
Run by
Astellas Pharma Inc
People needed
45
Starts
2005-01-01
Expected to finish
2006-08-01
Last updated by the study team
2012-06-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.